Evidence map›Paper›PMID 42059198›Full record

ArticleNucleic acids research2026

Operating CRISPR/Cas12a in a complex nucleic acid sequence background.

Henning Hellmer, Thomas Mayer, Lea Bauersachs, Friedrich C Simmel

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henning HellmerDepartment of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany.ORCID 0000-0003-3727-5676
Thomas MayerDepartment of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany.ORCID 0000-0001-8918-2979
Lea BauersachsDepartment of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany.ORCID 0009-0000-6469-6922
Friedrich C SimmelDepartment of Bioscience, School of Natural Sciences, Technical University of Munich, Garching, D-85748, Germany.ORCID 0000-0003-3829-3446

Funding

Deutsche Forschungsgemeinschaft 453249455Deutsche Forschungsgemeinschaft 521256690-TPA5Deutsche Forschungsgemeinschaft CRC392 TP A5Deutsche Forschungsgemeinschaft SI761/5-1
6 · The paper itself

Abstract

Since their discovery, CRISPR-Cas systems have been widely applied in areas ranging from genome editing to biosensing, owing to their specific, RNA-guided target recognition. Their performance in complex biological environments has been extensively studied, particularly to optimize guide RNA (gRNA) design and minimize off-target cleavage. Here, we focus on the kinetic inhibition of the interaction between Cas12a-a Class 2, Type V effector-and its target, caused by interference from non-cognate background nucleic acids. This effect is particularly relevant for sensing applications in complex mixtures or cellular contexts, where genome- and transcriptome-derived sequences may impede CRISPR-Cas activity. Using in vitro assays under defined conditions, we systematically examine the influence of background single-stranded RNA and double-stranded DNA (dsDNA) on reaction kinetics. We find that both the purine-to-pyrimidine ratio and the GC content of the gRNA seed region significantly affect kinetic inhibition by background polynucleotides. gRNAs with low GC content and a high purine fraction in the seed region were least affected by background sequences. A gRNA with high uracil content in the seed region exhibited particularly strong inhibition in the presence of a dsDNA background. Experiments with dCas12a-based gene activation in living cells indicate that our in vitro findings may also be relevant for in vivo applications.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsEndodeoxyribonucleasesRNA, Guide, CRISPR-Cas SystemsBase CompositionBase SequenceDNAKineticsRNABacterial ProteinsCas12a proteinCRISPR-Associated ProteinsDNAEndodeoxyribonucleasesRNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID42059198
PMCPMC13129545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.